| Smiles |
SCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C1(NC(=O)CC1))CC=2(N=CNC=2))CC=4(C3(=C(C=CC=C3)NC=4)))CO)CC(C)C)C(=O)NC(C(=O)NC(C(=O)N5(C(C(=O)NCC(=O)N)CCC5))C)CC=6(N=CNC=6)
|
| CAS number |
196863-62-4
|
| Polar Surface Area |
457,48
|
| calculated LogS |
-4,175
|
| Molweight |
1117,26
|
| calculated LogP |
-5,3421
|
| H-Acceptors |
28
|
| H-Donors |
14
|
| Ro5 violations |
3
|
| Druglikeness |
6,1472
|
| DrugScore |
0,4236217
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,7844
|
| Rat Acute Toxicity |
2,6655
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
-0,4013
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Non-inhibitor
|
| P-glycoprotein Inhibitor2 |
Non-inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,3721
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB-
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
Low HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA+
|
| Structure |
196863-62-4
|
